Mesoblast
MESO
$5.11
Share price
2.00%
Change (1 day)
51.18%
Change (1 year)
Categories
Mesoblast (MESO) - Total liabilities
Total liabilities on the balance sheet as of June 2023 : $0.16 B
According to Mesoblast 's latest financial reports the company's total liabilities are $0.16 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Mesoblast - Total liabilities on balance sheet (from 2012 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-06-30 | $0.16 B | 1.5% |
| 2022-06-30 | $0.16 B | 1.09% |
| 2021-06-30 | $0.16 B | -11.37% |
| 2020-06-30 | $0.18 B | 7.72% |
| 2019-06-30 | $0.17 B | 16.82% |
| 2018-06-30 | $0.14 B | 5.41% |
| 2017-06-30 | $0.13 B | -10.87% |
| 2016-06-30 | $0.15 B | -50.33% |
| 2015-06-30 | $0.31 B | -4.22% |
| 2014-06-30 | $0.32 B | 29.26% |
| 2013-06-30 | $0.25 B | 4.9% |
| 2012-06-30 | $0.24 B | -2.34% |
| 2011-06-30 | $0.24 B | 15406.41% |
| 2010-06-30 | $1.59 M | 34.64% |
| 2009-06-30 | $1.18 M | -24.65% |
| 2008-06-30 | $1.57 M | 125.04% |
| 2007-06-30 | $0.69 M | -84.41% |
| 2006-06-30 | $4.48 M | 103.46% |
| 2005-06-30 | $2.2 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $3.14 M | -98.12% | Bahamas |
 NRC Health
NRC | $73.48 M | -56.15% | 🇺🇸 USA |